Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G J Dover

Showing results (51-60 of 80) with videos related to

Pageof 8
Sort By:
The New England Journal of Medicine|August 9, 1990
Treatment of sickle cell anemia with hydroxyurea and erythropoietinM A Goldberg, C Brugnara, G J Dover, et al.
Progress in Clinical and Biological Research|January 1, 1989
Induction of fetal hemoglobin in sickle cell patients by hydroxyurea: the N.I.H. experienceG P Rodgers, G J Dover, C T Noguchi, et al.
Blood|February 1, 1979
Selective hemolysis of adult red blood cells: an aid to prenatal diagnosis of hemoglobinopathiesB P Alter, J B Metzger, P G Yock, et al.
The New England Journal of Medicine|June 15, 1995
Extended therapy with intravenous arginine butyrate in patients with beta-hemoglobinopathiesG D Sher, G D Ginder, J Little, et al.
Progress in Clinical and Biological Research|January 1, 1985
Pharmacologic manipulation of fetal hemoglobin synthesisG J Dover, R K Humphries, N Young, et al.
Blood|January 1, 1995
Oral sodium phenylbutyrate therapy in homozygous beta thalassemia: a clinical trialA F Collins, H A Pearson, P Giardina, et al.
Blood|February 1, 1997
Fetal hemoglobin in sickle cell anemia: determinants of response to hydroxyurea. Multicenter Study of HydroxyureaM H Steinberg, Z H Lu, F B Barton, et al.
Blood|March 1, 1977
Changing erythrocyte populations in juvenile chronic myelocytic leukemia: evidence for disordered regulationG J Dover, S H Boyer, W H Zinkham, et al.
The New England Journal of Medicine|January 14, 1993
Augmentation by erythropoietin of the fetal-hemoglobin response to hydroxyurea in sickle cell diseaseG P Rodgers, G J Dover, N Uyesaka, et al.
Blood|July 11, 1991
Effects of hydroxyurea on hemoglobin F and water content in the red blood cells of dogs and of patients with sickle cell anemiaE P Orringer, D S Blythe, A E Johnson, et al.
Pageof 8

Showing results (51-60 of 80) with videos related to

Sort By:
Pageof 8
The New England Journal of Medicine|August 9, 1990
Treatment of sickle cell anemia with hydroxyurea and erythropoietinM A Goldberg, C Brugnara, G J Dover, et al.
Progress in Clinical and Biological Research|January 1, 1989
Induction of fetal hemoglobin in sickle cell patients by hydroxyurea: the N.I.H. experienceG P Rodgers, G J Dover, C T Noguchi, et al.
Blood|February 1, 1979
Selective hemolysis of adult red blood cells: an aid to prenatal diagnosis of hemoglobinopathiesB P Alter, J B Metzger, P G Yock, et al.
The New England Journal of Medicine|June 15, 1995
Extended therapy with intravenous arginine butyrate in patients with beta-hemoglobinopathiesG D Sher, G D Ginder, J Little, et al.
Progress in Clinical and Biological Research|January 1, 1985
Pharmacologic manipulation of fetal hemoglobin synthesisG J Dover, R K Humphries, N Young, et al.
Blood|January 1, 1995
Oral sodium phenylbutyrate therapy in homozygous beta thalassemia: a clinical trialA F Collins, H A Pearson, P Giardina, et al.
Blood|February 1, 1997
Fetal hemoglobin in sickle cell anemia: determinants of response to hydroxyurea. Multicenter Study of HydroxyureaM H Steinberg, Z H Lu, F B Barton, et al.
Blood|March 1, 1977
Changing erythrocyte populations in juvenile chronic myelocytic leukemia: evidence for disordered regulationG J Dover, S H Boyer, W H Zinkham, et al.
The New England Journal of Medicine|January 14, 1993
Augmentation by erythropoietin of the fetal-hemoglobin response to hydroxyurea in sickle cell diseaseG P Rodgers, G J Dover, N Uyesaka, et al.
Blood|July 11, 1991
Effects of hydroxyurea on hemoglobin F and water content in the red blood cells of dogs and of patients with sickle cell anemiaE P Orringer, D S Blythe, A E Johnson, et al.
Pageof 8